Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;139(3):495-9.
doi: 10.1016/j.ygyno.2015.09.015. Epub 2015 Sep 24.

Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer

Affiliations

Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer

Valerie B Galvan-Turner et al. Gynecol Oncol. 2015 Dec.

Abstract

Objective: To develop an observed-to-expected ratio (O/E) for adherence to National Comprehensive Cancer Network (NCCN) ovarian cancer treatment guidelines as a risk-adjusted hospital measure of quality care correlated with disease-specific survival.

Methods: Consecutive patients with stages I-IV epithelial ovarian cancer were identified from the California Cancer Registry (1/1/96-12/31/06). Using a fit logistic regression model, O/E for guideline adherence was calculated for each hospital and distributed into quartiles stratified by hospital annual case volume: lowest O/E quartile or annual hospital case volume <5, middle two O/E quartiles and volume ≥5, and highest O/E quartile and volume ≥5. A multivariable logistic regression model was used to characterize the independent effect of hospital O/E on ovarian cancer-specific survival.

Results: Overall, 18,491 patients were treated at 405 hospitals; 37.3% received guideline adherent care. Lowest O/E hospitals (n=285) treated 4661 patients (25.2%), mean O/E=0.77±0.55 and median survival 38.9months (95%CI=36.2-42.0months). Intermediate O/E hospitals (n=85) treated 8715 patients (47.1%), mean O/E=0.87±0.17 and median survival of 50.5months (95% CI=48.4-52.8months). Highest O/E hospitals (n=35) treated 5115 patients (27.7%), mean O/E=1.34±0.14 and median survival of 53.8months (95% CI=50.2-58.2months). After controlling for other variables, treatment at highest O/E hospitals was associated with independent and statistically significant improvement in ovarian cancer-specific survival compared to intermediate O/E (HR=1.06, 95% CI=1.01-1.11) and lowest O/E (1.16, 95% CI=1.10-1.23) hospitals.

Conclusions: Calculation of hospital-specific O/E for NCCN treatment guideline adherence, combined with minimum case volume criterion, as a measure of ovarian cancer quality of care is feasible and is an independent predictor of survival.

Keywords: Hospitals; Humans; Ovarian cancer; Quality measurement; Risk assessment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Fig. 1
Fig. 1
Survival graph by O/E* category. Improved survival probability is noted when a minimum hospital case volume of 5 is combined with middle to high O/E. * O/E: observed-to-expected ratio.

References

    1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics 2014. CA Cancer J Clin. 2014;64:9–29. - PubMed
    1. Morgan RJ, Jr, Alvarez RD, Armstrong DK, Burger RA, Chen LM, et al. Ovarian cancer, version 2.2013. J Natl Compr Cancer Netw. 2013 Oct;11(10):1199–1209. - PubMed
    1. Bristow RE, Chang J, Ziogas A, Anton-Culver H. Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol. 2013;121:1226–1234. - PubMed
    1. Erickson BK, Martin YJ, Shah MM, Straughn JM, Leath CA. Reasons for failure to delivery national comprehensive cancer network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center. Gynecol Oncol. 2014;133:142–146. - PMC - PubMed
    1. Hillner BE, Smith TJ, Desch CE. Hospital and physician volume of specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol. 2000;18:2327–2340. - PubMed

Publication types